POU5F1 and lung cancer: It has been recently reported that Gal-3 promotes lung cancer stemness via the EGFR/c-Myc/Sox-2 pathway (24), and Oct4, a stemness-related transcription factor (47), favors Gal-3 expression, thus establishing a positive regulatory loop in lung CSCs (24).